The international myeloma foundation says revlimid meets important quality of life measures
April 15th, 2008 by 
admin NORTH HOLLYWOOD, Calif. & WURZBURG, Germany–(BUSINESS
WIRE)–April 11, 2008 - The International Myeloma Foundation (IMF)
- activity investigate and providing education, advocacy and support
for myeloma patients, families, researchers and… (Source: Drugs.com - Clinical Trials)
Posted in Cancer | 